Follow
Luis Almeida, MD, PhD
Luis Almeida, MD, PhD
BlueClinical
Verified email at blueclinical.pt - Homepage
Title
Cited by
Cited by
Year
Pharmacokinetic and safety profile of trans‐resveratrol in a rising multiple‐dose study in healthy volunteers
L Almeida, M Vaz‐da‐Silva, A Falcão, E Soares, R Costa, AI Loureiro, ...
Molecular nutrition & food research 53 (S1), S7-S15, 2009
4582009
Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial‐onset seizures: a randomized, double‐blind, placebo‐controlled …
C Elger, P Halász, J Maia, L Almeida, P Soares‐da‐Silva, ...
Epilepsia 50 (3), 454-463, 2009
2922009
Catechol‐O‐methyltransferase and Its Inhibitors in Parkinson's Disease
MJ Bonifácio, PN Palma, L Almeida, P Soares‐da‐Silva
CNS drug reviews 13 (3), 352-379, 2007
2312007
Eslicarbazepine acetate as adjunctive therapy in adult patients with partial epilepsy
E Ben-Menachem, AA Gabbai, A Hufnagel, J Maia, L Almeida, ...
Epilepsy research 89 (2-3), 278-285, 2010
2162010
Eslicarbazepine acetate (BIA 2-093)
L Almeida, P Soares-da-Silva
Neurotherapeutics 4 (1), 88-96, 2007
2102007
Efficacy and safety of 800 and 1200 mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial‐onset seizures
A Gil‐Nagel, J Lopes‐Lima, L Almeida, J Maia, P Soares‐da‐Silva, ...
Acta Neurologica Scandinavica 120 (5), 281-287, 2009
1952009
Eslicarbazepine acetate: a double‐blind, add‐on, placebo‐controlled exploratory trial in adult patients with partial‐onset seizures
C Elger, M Bialer, JA Cramer, J Maia, L Almeida, P Soares‐da‐Silva
Epilepsia 48 (3), 497-504, 2007
1532007
Single-dose and steady-state pharmacokinetics of eslicarbazepine acetate (BIA 2-093) in healthy elderly and young subjects
L Almeida, PS da Silva, A Falcão, J Maia, D Mazur, M Gellert
1192005
Pharmacokinetics of eslicarbazepine acetate in patients with moderate hepatic impairment
L Almeida, JH Potgieter, J Maia, MA Potgieter, F Mota, P Soares-da-Silva
European journal of clinical pharmacology 64 (3), 267-273, 2008
1102008
Pharmacokinetics of Trans‐resveratrol Following Repeated Administration in Healthy Elderly and Young Subjects
T Nunes, L Almeida, JF Rocha, A Falcão, C Fernandes‐Lopes, ...
The Journal of Clinical Pharmacology 49 (12), 1477-1482, 2009
1092009
Long‐term efficacy and safety of eslicarbazepine acetate: results of a 1‐year open‐label extension study in partial‐onset seizures in adults with epilepsy
P Halász, JA Cramer, D Hodoba, A Członkowska, A Guekht, J Maia, ...
Epilepsia 51 (10), 1963-1969, 2010
1082010
Effect of food on the pharmacokinetic profile of trans-resveratrol
M Vaz-da-Silva, AI Loureiro, A Falcao, T Nunes, JF Rocha, ...
Int J Clin Pharmacol Ther 46 (11), 564-70, 2008
1082008
Effect of renal impairment on the pharmacokinetics of eslicarbazepine acetate
J Maia, L Almeida, A Falcao, E Soares, F Mota, MA Potgieter, JH Potgieter, ...
International journal of clinical pharmacology and therapeutics 46 (3), 119, 2008
962008
Effect of renal impairment on the pharmacokinetics of eslicarbazepine acetate
J Maia, L Almeida, A Falcao, E Soares, F Mota, MA Potgieter, JH Potgieter, ...
International journal of clinical pharmacology and therapeutics 46 (3), 119, 2008
962008
Pharmacokinetics, pharmacodynamics and tolerability of opicapone, a novel catechol-o-methyltransferase inhibitor, in healthy subjects
L Almeida, JF Rocha, A Falcão, P Nuno Palma, AI Loureiro, R Pinto, ...
Clinical pharmacokinetics 52 (2), 139-151, 2013
942013
Efficacy and safety of eslicarbazepine acetate as add‐on treatment in patients with focal‐onset seizures: integrated analysis of pooled data from double‐blind phase III …
A Gil‐Nagel, C Elger, E Ben‐Menachem, P Halász, J Lopes‐Lima, ...
Epilepsia 54 (1), 98-107, 2013
902013
Why healthy subjects volunteer for phase I studies and how they perceive their participation?
L Almeida, B Azevedo, T Nunes, M Vaz-da-Silva, P Soares-da-Silva
European journal of clinical pharmacology 63 (11), 1085-1094, 2007
902007
Long-term safety and efficacy of eslicarbazepine acetate as adjunctive therapy in the treatment of partial-onset seizures in adults with epilepsy: results of a 1-year open …
A Hufnagel, E Ben-Menachem, AA Gabbai, A Falcão, L Almeida, ...
Epilepsy Research 103 (2-3), 262-269, 2013
842013
Opicapone: a short lived and very long acting novel catechol‐O‐methyltransferase inhibitor following multiple dose administration in healthy subjects
JF Rocha, L Almeida, A Falcão, PN Palma, AI Loureiro, R Pinto, ...
British journal of clinical pharmacology 76 (5), 763-775, 2013
802013
The Use of Procalcitonin (PCT) for Diagnosis of Sepsis in Burn Patients: A Meta-Analysis
L Cabral, V Afreixo, L Almeida, JA Paiva
PLoS ONE 11 (12), e0168475, 2016
772016
The system can't perform the operation now. Try again later.
Articles 1–20